Zymeworks Inc (ZYME:NASDAQ)
$24.08 -0.72 (-2.90%)
Analysed Zymeworks Inc (ZYME:NASDAQ) News Sources
Zymeworks Inc. Q4 2025 Earnings Call Summary
Yahoo Finance
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
Yahoo Finance
Zymeworks FY25 Review: From Milestone Volatility To 2026 Upside
Seeking Alpha
Zymeworks Inc. (ZYME) Reports Q4 Loss, Lags Revenue Estimates
Yahoo Finance UK
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
Markets Insider
Zymeworks outlines $1.5B milestone potential and signals milestone-driven expansion strategy through 2028
Seeking Alpha
Zymeworks and Royalty Pharma enter into $250 million deal
The Pharma Letter
Earnings Breakdown: Zymeworks Q4
Benzinga
Epson to Showcase its Portfolio of Healthcare Solutions at HIMSS 2026
Le Lézard
Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands
Le Lézard
What is the current price of Zymeworks Inc (ZYME:NASDAQ)?
The current price of Zymeworks Inc (ZYME:NASDAQ) is $24.08.
Zymeworks Inc (ZYME:NASDAQ) absolute price change since previous trading day?
The absolute price change of Zymeworks Inc (ZYME:NASDAQ) since the previous trading day is $-0.72.
Zymeworks Inc (ZYME:NASDAQ) percentage price change since previous trading day?
The percentage price change of Zymeworks Inc (ZYME:NASDAQ) since the previous trading day is -2.90%.
What is This Week's average sentiment score for Zymeworks Inc (ZYME:NASDAQ)?
This Week's average sentiment score for Zymeworks Inc (ZYME:NASDAQ) is 87 out of 100.
What is This Week's average sentiment for Zymeworks Inc (ZYME:NASDAQ)?
This Week's sentiment for Zymeworks Inc (ZYME:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.